Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renal-cell carcinoma--molecular pathways and therapies.

× No keyword cloud information.

74 in total

Review 1. Treatment of metastatic renal cell carcinoma.

Authors: Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Pierre I Karakiewicz
Journal: Nat Rev Urol Date: 2010-05-11 Impact factor: 14.432

Review 2. Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.

Authors: Venkata S Katabathina; Nathalie Lassau; Ivan Pedrosa; Chaan S Ng; Srinivasa R Prasad
Journal: Curr Urol Rep Date: 2012-02 Impact factor: 3.092

3. Predictive factors for response to treatment in patients with advanced renal cell carcinoma.

Authors: Carolina Muriel López; Emilio Esteban; Aurora Astudillo; Pablo Pardo; Jose Pablo Berros; Marta Izquierdo; Guillermo Crespo; Paula J Fonseca; Miguel Sanmamed; Pablo Martínez-Camblor
Journal: Invest New Drugs Date: 2012-05-27 Impact factor: 3.850

4. Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma.

Authors: Rit Vatsyayan; Jyotsana Singhal; Lokesh Dalasanur Nagaprashantha; Sanjay Awasthi; Sharad S Singhal
Journal: Mol Carcinog Date: 2011-10-17 Impact factor: 4.784

5. Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months.

Authors: Christopher Straka; D W Nathan Kim; Robert D Timmerman; Ivan Pedrosa; Corbin Jacobs; James Brugarolas
Journal: J Clin Oncol Date: 2013-06-24 Impact factor: 44.544

6. Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.

Authors: Heloisa Veasey Rodrigues; Danxia Ke; JoAnn Lim; Bettzy Stephen; Jorge Bellido; Filip Janku; Ralph Zinner; Apostolia Tsimberidou; David Hong; Sarina Piha-Paul; Siqing Fu; Aung Naing; Vivek Subbiah; Daniel Karp; Gerald Falchook; Razelle Kurzrock; Jennifer Wheler
Journal: Invest New Drugs Date: 2015-04-24 Impact factor: 3.850

Review 7. The role of functional imaging in the era of targeted therapy of renal cell carcinoma.

Authors: Margarita Braunagel; Anno Graser; Maximilian Reiser; Mike Notohamiprodjo
Journal: World J Urol Date: 2013-04-16 Impact factor: 4.226

Review 8. The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Authors: Antonio Romo de Vivar Chavez; Michael E de Vera; Xiaoyan Liang; Michael T Lotze
Journal: Med Oncol Date: 2009-01-16 Impact factor: 3.064

9. Anti-angiogenesis approach to genitourinary cancer treatment.

Authors: Jeanny B Aragon-Ching; William L Dahut
Journal: Update Cancer Ther Date: 2009

10. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.

Authors: Guoqiang Li; Weimin Ci; Subhradip Karmakar; Ke Chen; Ruby Dhar; Zhixiang Fan; Zhongqiang Guo; Jing Zhang; Yuwen Ke; Lu Wang; Min Zhuang; Shengdi Hu; Xuesong Li; Liqun Zhou; Xianghong Li; Matthew F Calabrese; Edmond R Watson; Sandip M Prasad; Carrie Rinker-Schaeffer; Scott E Eggener; Thomas Stricker; Yong Tian; Brenda A Schulman; Jiang Liu; Kevin P White
Journal: Cancer Cell Date: 2014-03-20 Impact factor: 31.743